These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37795416)

  • 41. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
    Schachtner T; Zaks M; Kahl A; Reinke P
    Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients.
    Silvano J; Ferreira F; Bustorff M; Nunes AT; Tavares I; Sobrinho Simões J; Ramos A; Cardoso MJ; Sampaio S; Pestana M
    Transplant Proc; 2021 May; 53(4):1180-1186. PubMed ID: 33419577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients.
    Gueguen J; Colosio C; Del Bello A; Scemla A; N'Guyen Y; Rouzaud C; Carvalho-Schneider C; Gautier Vargas G; Tremolières P; Eddine AJ; Masset C; Thaunat O; Chabannes M; Malvezzi P; Pommerolle P; Couzi L; Kamar N; Caillard S; Gatault P
    Kidney Int Rep; 2022 Jun; 7(6):1241-1247. PubMed ID: 35372734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19.
    Zheng Z; Sun H; Hu X; Xuan Z; Fu M; Bai Y; Du Y; Liu B; Sui X; Zheng J; Shao C
    Front Med (Lausanne); 2024; 11():1287836. PubMed ID: 38633308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.
    Mehta SA; Leonard J; Labella P; Cartiera K; Soomro I; Neumann H; Montgomery RA; Ali NM
    Transpl Infect Dis; 2020 Dec; 22(6):e13383. PubMed ID: 32578324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report.
    Zahradka I; Petr V; Modos I; Magicova M; Dusek L; Viklicky O
    Ann Intern Med; 2022 Jul; 175(7):961-968. PubMed ID: 35500256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iranian kidney transplant recipients with COVID-19 infection: Clinical outcomes and cytomegalovirus coinfection.
    Molaei H; Khedmat L; Nemati E; Rostami Z; Saadat SH
    Transpl Infect Dis; 2021 Feb; 23(1):e13455. PubMed ID: 32881220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
    Kho MML; Messchendorp AL; Frölke SC; Imhof C; Koomen VJ; Malahe SRK; Vart P; Geers D; de Vries RD; GeurtsvanKessel CH; Baan CC; van der Molen RG; Diavatopoulos DA; Remmerswaal EBM; van Baarle D; van Binnendijk R; den Hartog G; de Vries APJ; Gansevoort RT; Bemelman FJ; Reinders MEJ; Sanders JF; Hilbrands LB;
    Lancet Infect Dis; 2023 Mar; 23(3):307-319. PubMed ID: 36354032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
    Al Jurdi A; Gassen RB; Borges TJ; Solhjou Z; Hullekes FE; Lape IT; Efe O; Alghamdi A; Patel P; Choi JY; Mohammed MT; Bohan B; Pattanayak V; Rosales I; Cravedi P; Kotton CN; Azzi JR; Riella LV
    Front Immunol; 2022; 13():838985. PubMed ID: 35281011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of COVID-19 on Kidney Graft Function One Year after Onset.
    Malinowska A; Ruszkowski J; Muchlado M; Ślizień Z; Heleniak Z; Parczewska A; Kanclerz K; Biedunkiewicz B; Tylicki L; Król E; Dębska-Ślizień A
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256287
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
    Körber N; Holzmann-Littig C; Wilkens G; Liao BH; Werz ML; Platen L; Cheng CC; Tellenbach M; Kappler V; Lehner V; Mijočević H; Christa C; Assfalg V; Heemann U; Schmaderer C; Protzer U; Braunisch MC; Bauer T; Renders L
    Front Immunol; 2023; 14():1172477. PubMed ID: 37063863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.
    Benotmane I; Risch S; Doderer-Lang C; Caillard S; Fafi-Kremer S
    Am J Transplant; 2021 Aug; 21(8):2871-2875. PubMed ID: 33961334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
    Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
    Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
    Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
    An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
    Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
    Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.
    Chavarot N; Morel A; Leruez-Ville M; Vilain E; Divard G; Burger C; Serris A; Sberro-Soussan R; Martinez F; Amrouche L; Bererhi L; Lanternier F; Legendre C; Zuber J; Anglicheau D; Scemla A
    Am J Transplant; 2021 Dec; 21(12):4043-4051. PubMed ID: 34431207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients.
    Pommerolle P; Laurent P; Presne C; Brazier F; Jaureguy M; Poulain C; Flahaut G; Mazouz H; Brochot E; Choukroun G; Fourdinier O
    Adv Ther; 2023 Sep; 40(9):3956-3970. PubMed ID: 37392339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical activity and renal function in the Italian kidney transplant population.
    Masiero L; Puoti F; Bellis L; Lombardini L; Totti V; Angelini ML; Spazzoli A; Nanni Costa A; Cardillo M; Sella G; Mosconi G
    Ren Fail; 2020 Nov; 42(1):1192-1204. PubMed ID: 33256487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns in Use and Transplant Outcomes Among Adult Recipients of Kidneys From Deceased Donors With COVID-19.
    Ji M; Vinson AJ; Chang SH; Merzkani M; Lentine KL; Caliskan Y; Progar K; Nesselhauf N; Dubrawka C; Alhamad T
    JAMA Netw Open; 2023 May; 6(5):e2315908. PubMed ID: 37252739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.